Pfizer-BioNTech Seeks Emergency Use of Covid Booster for Children Aged 5-11 Pfizer-BioNTech seeks an FDA emergency use approval in the US for children aged 5-11. This booster dose is intended for the original Covid strain, Omicron, and BA.4 and BA.5 subvariants. by Joaquin Victor Tacla
Health Moderna Sues Pfizer, BioNTech for Use of mRNA Technology in COVID Vaccines—Pfizer Responds by Isaiah Richard
Health Pfizer-BioNTech COVID-19 Now Has 100% Effeciency: Can It Prevent Europe's New Variant by Giuliano J. de Leon
Health COVID-19 Vaccine Can Be Used Against Coronavirus Mutation, Pfizer/BioNTech Study Shows by Sieeka Khan
Science FDA Passes Pfizer and BioNTech COVID-19 Vaccines, Announces High-Risk Groups to be Vaccinated First by Sieeka Khan
Health FDA Approves Pfizer's COVID-19 Vaccine Emergency Use Despite Fears From Severe Allergic Reactions Reported in UK by Isaiah Alonzo
Xi Jinping Warns Against Chip Restrictions During Talks with Dutch PM Rutte: 'No Force Can Stop China's Progress'
Researchers Achieve Record Data Transmission Speed, 4.5 Million Times Faster Than Average Home Broadband